Info

Immunicon is developing and commercializing diagnostic and research products for rare cell analysis, with an initial focus on cancer. Reagent kits incorporating Immunicon proprietary technology are used with our instrument systems to capture, count and characterize circulating tumor cells or circulating endothelial cells from whole blood.